Anti-dementia bias and Medicare regulation of Alzheimer's disease care

被引：0
|
作者：
Stern, Andrew M. M. [1 ]
机构：
[1] Brigham & Womens Hosp, Dept Neurol, 60 Fenwood Rd10006, Boston, MA 02115 USA
来源：
ALZHEIMERS & DEMENTIA | 2023年 / 19卷 / 08期
关键词：
D O I：
10.1002/alz.13166
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：3752 / 3753
页数：2
相关论文
共 50 条
  • [41] Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer's Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study
    Hong, Yun Jeong
    Choi, Seong Hye
    Jeong, Jee Hyang
    Park, Kyung Won
    Na, Hae Ri
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (03) : 1035 - 1044
  • [42] Sudden discontinuation of anti-dementia drugs in moderate and severe Alzheimer's disease in a residency for dependent elderly people: a longitudinal descriptive pilot study
    Saint Paul, L. Peyro
    Martin, J.
    Gaillard, C.
    Garnier, A.
    Mosquet, B.
    Guillamo, J. S.
    Parienti, J. J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 26 - 26
  • [43] Gender Disparities in Anti-dementia Medication Use among Older Adults: Health Equity Considerations and Management of Alzheimer's Disease and Related Dementias
    Lu, Z. Kevin
    Xiong, Xiaomo
    Wang, Xinyuan
    Wu, Jun
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] Medicare expenditures for beneficiaries with dementia of the Alzheimer's type
    Weiner, M
    Powe, NR
    Anderson, GF
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (10) : 1276 - 1276
  • [45] No evidence exists that "anti-dementia" drugs modify disease or improve outcome
    Gordon, Peter J.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [46] Alzheimer's disease or other dementia and medical care utilization
    Eaker, ED
    Mickel, SF
    Chyou, PH
    Mueller-Rizner, NJ
    Slusser, JP
    ANNALS OF EPIDEMIOLOGY, 2002, 12 (01) : 39 - 45
  • [47] Anti-dementia drugs in patients with Alzheimer's disease and the risk of developing seizures or epilepsy: a population-based nested case-control analysis
    Imfeld, P.
    Bodmer, M.
    Jick, S. S.
    Meier, C. R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 871 - 871
  • [48] Gait Changes with Anti-Dementia Drugs: A Prospective, Open-Label Study Combining Single and Dual Task Assessments in Patients with Alzheimer’s Disease
    Olivier Beauchet
    Cyrille P. Launay
    Gilles Allali
    François R. Herrmann
    Cedric Annweiler
    Drugs & Aging, 2014, 31 : 363 - 372
  • [49] Gait Changes with Anti-Dementia Drugs: A Prospective, Open-Label Study Combining Single and Dual Task Assessments in Patients with Alzheimer's Disease
    Beauchet, Olivier
    Launay, Cyrille P.
    Allali, Gilles
    Herrmann, Francois R.
    Annweiler, Cedric
    DRUGS & AGING, 2014, 31 (05) : 363 - 372
  • [50] Anti-Dementia Drugs in Patients with Alzheimer's Disease and the Risk of Developing Seizures or Epilepsy: A Population-Based Nested Case-Control Analysis
    Imfeld, Patrick
    Bodmer, Michael
    Jick, Susan S.
    Meier, Christoph R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 332 - 333
12345